Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Kuenz, Bettina ^a   Lutterotti, Andreas ^a   Ehling, Rainer ^a   Gneiss, Claudia ^a   Haemmerle, Monika ^a   Rainer, Carolyn ^a   Deisenhammer, Florian ^a   Schocke, Michael ^a   Berger, Thomas ^a   Reindl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CXCL13 CHEMOKINE; GELATINASE B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SYNDECAN 1; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLAST CELL; CELL AGGREGATION; CELL POPULATION; CEREBROSPINAL FLUID CYTOLOGY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENCEPHALITIS; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; CEREBROSPINAL FLUID; CYTOLOGY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; ENCEPHALITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES;

EID: 49749121806     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002559     Document Type: Article

References (39)

1. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747.
2. Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis-the plaque and its pathogenesis. N Engl J Meal 354:942-955.
3. Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17: 210-218.
4. Kabat EA, Glusman M, Knaub V (1948) Quantitative estimation of the albumin and gamma-globulin in normal and pathological cerebrospinal fluid by immunochemical methods. Am J Med 4: 653-662.
5. Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, et al. (2000) Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164: 2782-2789.
6. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, et al. (1999) B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163: 5133-5144.
7. Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, et al. (1998) Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 43: 236-243.
8. Owens GP, Ritchie AM, Burgoon MP, Williamson RA, Corboy JR, et al. (2003) Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 171: 2725-2733.
9. Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, et al. (1998) Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 102: 1045-1050.
10. Meinl E, Krumbholz M, Hohlfeld R (2006) B lineage cells in the inflammatory, central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol 59: 880-892.
11. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 6: 259-274.
12. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, et al. (1998) Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 43:465-471.
13. Bar-Or A, Calabresi PA, Arnlod D, Markowitz C, Shafer S, et al. (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63: 395-400.
14. Cross AH, Stark JL, Lauber J, Ramsbottom MJ, Lyons JA (2006) Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 180: 63-70.
15. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, et al. (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358: 676-688.
16. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, et al. (2001) Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 124: 2169 2176.
17. Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, et al. (2005) Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128: 1667 1676.
18. Cepok S, von Geldern G, Nolting T, Grummel V, Srivastava R, et al. (2007) Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection. Ann Neurol 62: 458-467.
19. Cepok S, Zhou D, Vogel F, Rosche B, Grummel V, et al. (2003) The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch Neurol 60: 849 855.
20. Corcione A. Casazza S, Ferretti E, Giunti D, Zappia E, el al. (2004) Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis, Proc Natl Acad Sci U S A 101: 11064 11069.
21. Cepok S, von Geldern G, Grummel V, Hochgesand S, Celik H. et al. (2006) Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation. J Neuroimmunol 180: 33 39.
22. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154: 4379-4389.
23. Yong VW, Krekoski CA. Forsyth PA. Bell R. Edwards DR (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21: 75-80.
24. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128: 2705 2712
25. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14: 164 174.
26. Uccelli A, Aloisi F, Pistoia V (2005) Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol 26: 254-259.
27. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, et al. (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130: 1089-1104.
28. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, et al. (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129: 200-211.
29. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
30. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, et al. (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62: 865 870.
31. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121 127.
32. Stuve O, Marra CM, Jerome KR, Cook L, Cravens PD, et al. (2006) Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol 59: 743 747.
33. Magliozzi R, Columba-Cabezas S, Serafini B, Aloisi F (2004) Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in die meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 118: 11-23.
34. Luther SA. Ansel KM. Cyster JG (2003) Overlapping roles of CXCL13, interleukin 7 receptor alpha. and CCR7 ligands in lymph node development J Exp Med 197: 1191-1198
35. Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, et al. (2005) BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201: 195-200.
36. Leppert D, Ford J, Stabler G, Grygar C, Lienert C, et al. (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121 (Pt 12): 2327-2334.
37. Liuzzi GM, Trojano M, Fanelli M, Avolio C, Fasano A, et al. (2002) Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult Scler 8: 222-228.
38. Di Girolamo N, Tedla N, Lloyd A, Wakefield D (1998) Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol 28: 1773 1784.
39. Trocme C, Gaudin P, Berthier S, Barro C, Zaoui P, et al. (1998) Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9. J Biol Chem 273: 20677-20684.